drugset / Trial / NCT02698618
PRotective Effect on the Coronary Microcirculation of Patients With DIabetes by Clopidogrel or Ticagrelor
Phase 4
Unknown
50 enrolled
Fundacion Investigacion Interhospitalaria Cardiovascular
AstraZeneca · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether Ticagrelor has a protective effect on microcirculation during percutaneous coronary interventions in patients with Diabetes mellitus type II or in a pre-diabetic status.
Timeline
- Start
- 2016-03
- Primary completion
- 2017-03
- Completion
- 2017-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clopidogrel | Small molecule | 75 mg | — |
| Subject | Ticagrelor | Small molecule | 90 mg | — |